Status:
COMPLETED
Spartan Cube CYP2C19 Method Comparison Study
Lead Sponsor:
Spartan Bioscience Inc.
Collaborating Sponsors:
Mount Sinai Services
Conditions:
Genotyping Techniques
Eligibility:
All Genders
Phase:
NA
Brief Summary
The aim of the study is to demonstrate concordance (percent agreement) between results produced by the Spartan CYP2C19 system and bi-directional sequencing. In addition, this study will evaluate the c...
Detailed Description
Sample holding time - two parts 1. Sample tested in less than one-hour a.In the first part, buccal samples will be collected from subjects and tested using the Spartan Cube CYP2C19 system. These ...
Eligibility Criteria
Inclusion
- Participants who will provide buccal samples and a saliva sample who have not eaten drank or smoked in the past 30 minutes.
Exclusion
- Participants who have eaten drank or smoked in the past 30 minutes prior to collection.
Key Trial Info
Start Date :
February 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 6 2020
Estimated Enrollment :
425 Patients enrolled
Trial Details
Trial ID
NCT04473586
Start Date
February 5 2020
End Date
March 6 2020
Last Update
July 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Services
Toronto, Ontario, Canada, M5G1Z5